Effects of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties on cerebral dopamine and serotonin levels in rats

被引：0
|
作者：
Assié, M
Ravailhe, V
Faucillon, V
Newman-Tancredi, A
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [41] Reversal of phencyclidine stimulated basolateral amygdala dopamine and noradrenaline release by aripiprazole but not clozapine, ziprasidone and haloperidol involves dopamine D2 and serotonin 5-HT1A receptors
    Glennon, J
    Lewis, L
    Van de Kooij, M
    McCreary, AC
    Hamelink, R
    Leguit, N
    Tros, R
    Kleefstra, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S518 - S519
  • [42] Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies
    Brindisi, Margherita
    Butini, Stefania
    Franceschini, Silvia
    Brogi, Simone
    Trotta, Francesco
    Ros, Sindu
    Cagnotto, Alfredo
    Salmona, Mario
    Casagni, Alice
    Andreassi, Marco
    Saponara, Simona
    Gorelli, Beatrice
    Weikop, Pia
    Mikkelsen, Jens D.
    Scheel-Kruger, Jorgen
    Sandager-Nielsen, Karin
    Novellino, Ettore
    Campiani, Giuseppe
    Gemma, Sandra
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (22) : 9578 - 9597
  • [43] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors
    A. Newman-Tancredi
    D. Cussac
    V. Audinot
    M. J. Millan
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 447 - 453
  • [44] Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase
    Slot, LAB
    De Vries, L
    Newman-Tancredi, A
    Cussac, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 534 (1-3) : 63 - 70
  • [45] A NOVEL CELL LINE FOR STUDYING DOPAMINE D2 AND SEROTONIN 5-HT2A HETERODIMERIZATION
    Gomez Fernandez, S.
    Lopez-Gimenez, J. F.
    Varela, M. J.
    Marcia-Rivas, M. D.
    Cadavid, M., I
    Brea, J.
    Loza, M., I
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 38 - 38
  • [46] Paroxetine and Low-dose Risperidone Induce Serotonin 5-HT1A and Dopamine D2 Receptor Heteromerization in the Mouse Prefrontal Cortex
    Kolasa, Magdalena
    Solich, Joanna
    Faron-Gorecka, Agata
    Zurawek, Dariusz
    Pabian, Paulina
    Lukasiewicz, Sylwia
    Kusmider, Maciej
    Szafran-Pilch, Kinga
    Szlachta, Marta
    Dziedzicka-Wasylewska, Marta
    NEUROSCIENCE, 2018, 377 : 184 - 196
  • [47] THE EFFECT OF GYKI-32-887 ON DOPAMINE (D2) AND SEROTONIN (5-HT1 AND 5-HT2) RECEPTORS
    BERZETEI, IP
    BAGDY, E
    HARDY, M
    BORSY, J
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1985, 37 (03): : 237 - 242
  • [48] INTERACTION OF SEROTONIN (5-HT1A) LIGANDS WITH DOPAMINE-MEDIATED BEHAVIORS IN THE RAT
    BROCCO, M
    BERVOETS, K
    GOBERT, A
    MAVRIDIS, M
    RIVET, JM
    MILLAN, MJ
    FASEB JOURNAL, 1992, 6 (05): : A1869 - A1869
  • [49] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Blasi, Giuseppe
    Selvaggi, Pierluigi
    Fazio, Leonardo
    Antonucci, Linda Antonella
    Taurisano, Paolo
    Masellis, Rita
    Romano, Raffaella
    Mancini, Marina
    Zhang, Fengyu
    Caforio, Grazia
    Popolizio, Teresa
    Apud, Jose
    Weinberger, Daniel R.
    Bertolino, Alessandro
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (07) : 1600 - 1608
  • [50] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Giuseppe Blasi
    Pierluigi Selvaggi
    Leonardo Fazio
    Linda Antonella Antonucci
    Paolo Taurisano
    Rita Masellis
    Raffaella Romano
    Marina Mancini
    Fengyu Zhang
    Grazia Caforio
    Teresa Popolizio
    Jose Apud
    Daniel R Weinberger
    Alessandro Bertolino
    Neuropsychopharmacology, 2015, 40 : 1600 - 1608
12345